Stock Scorer

BioLineRx Ltd. (BLRX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 2M 4M 6M Q2 '23: 0 Q2 '24: 5.4M Q2 '25: 304K Q2 '23 Q2 '24 Q2 '25

Gross Profit Quarterly

0 2M 4M 6M Q2 '23: 0 Q2 '24: 4.5M Q2 '25: 232K Q2 '23 Q2 '24 Q2 '25

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '17: -5.2M Q2 '18: -5.7M Q2 '19: -6.5M Q2 '20: -5.6M Q2 '21: -6.5M Q2 '22: -7.6M Q2 '23: -9.9M Q2 '24: -5.8M Q2 '25: -2.3M Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q2 '17: -4.9M Q2 '18: -4.8M Q2 '19: -5.5M Q2 '20: -6.8M Q2 '21: -6.8M Q2 '22: -7.4M Q2 '23: -18.5M Q2 '24: 484K Q2 '25: -3.9M Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Cost of Revenue Quarterly

0 350K 700K 1.1M Q2 '23: 0 Q2 '24: 897K Q2 '25: 72K Q2 '23 Q2 '24 Q2 '25

Shares Outstanding Quarterly

0 900M 1.8B 2.7B Q2 '17: 94.5M Q2 '18: 106.6M Q2 '19: 145.5M Q2 '20: 220.3M Q2 '21: 669.1M Q2 '22: 715.4M Q2 '23: 923M Q2 '24: 1.2B Q2 '25: 2.4B Q2 '17 Q2 '19 Q2 '21 Q2 '23 Q2 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS Annual

-0.08 -0.05 -0.03 0.00 0.03 0.05 0.08 FY21: -0.04 FY22: -0.03 FY23: -0.06 FY24: -0.01 FY25: 0.00 FY21 FY22 FY23 FY24 FY25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BLRX: Operating Cash Flow, Free Cash Flow. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.